2 Results were found on Technologies

Leading Researchers:

Unique Cocktail of Neutralizing Antibodies against SARS-CoV-2

We have identified eight potent neutralizing antibodies (mAbs) from recovered COVID-19 patients for COVID-19 treatment. These antibodies may be used as pre-exposure prophylaxis, i.e., as short-term protection from infection for populations at risk and highly exposed medical teams or those that did not develop enough antibodies post vaccinationUNMET NEEDThe COVID-19 pandemic caused by SARS-CoV-2, has […] Read More >

Leading Researchers:

Plant-Derived Anti- Herpesvirus Composition

Herpes simplex virus infection is commonly known as herpes. The two types of herpes simplex virus are HSV-1 (known to cause orofacial disease such as cold sores) and HSV-2 (causes genital infections). Over 80% of herpes infections is asymptomatic. Symptomatic infections are presented with blistering sores, pain during urination, swollen lymph nodes, and fever. Acyclovir […] Read More >

Prof. FRENKEL Niza

Current research projects: Molecular mechanisms of herpesvirus replication and gene expression Disease associations of the lymphotropic Human herpesviruseses 6A, 6B and 7 (HHV-6A, HHV-6B and HHV-7). Derivation of herpesvirus vectors towards their use in gene therapy and vaccination. Molecular Virology: Studies of viral DNA replication and packaging; Virus-host cell interactions including HSV-1 host shutoff by […] Read More >

Dr. Freund Natalia

Senior Lecturer (Guest), Department of Clinical Microbiology and Immunology, Faculty of Medicine Research My laboratory is interested in understanding the molecular basis of human antibody responses to diseases. Antibodies are key components of most licensed vaccines; nevertheless many aspects of how antibodies recognize and neutralize their targets are still unknown. Pathogen-specific B cells are stimulated […] Read More >

Sorry, no results were found.

Sign up for
our events

    Life Science